全文获取类型
收费全文 | 664篇 |
免费 | 29篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 39篇 |
妇产科学 | 8篇 |
基础医学 | 64篇 |
口腔科学 | 16篇 |
临床医学 | 83篇 |
内科学 | 145篇 |
皮肤病学 | 40篇 |
神经病学 | 23篇 |
特种医学 | 123篇 |
外科学 | 47篇 |
综合类 | 22篇 |
预防医学 | 31篇 |
眼科学 | 4篇 |
药学 | 24篇 |
1篇 | |
肿瘤学 | 23篇 |
出版年
2023年 | 1篇 |
2022年 | 3篇 |
2021年 | 3篇 |
2020年 | 3篇 |
2019年 | 6篇 |
2018年 | 9篇 |
2017年 | 4篇 |
2016年 | 9篇 |
2015年 | 13篇 |
2014年 | 15篇 |
2013年 | 19篇 |
2012年 | 8篇 |
2011年 | 19篇 |
2010年 | 31篇 |
2009年 | 30篇 |
2008年 | 20篇 |
2007年 | 31篇 |
2006年 | 19篇 |
2005年 | 22篇 |
2004年 | 15篇 |
2003年 | 8篇 |
2002年 | 18篇 |
2001年 | 15篇 |
2000年 | 11篇 |
1999年 | 11篇 |
1998年 | 40篇 |
1997年 | 45篇 |
1996年 | 38篇 |
1995年 | 19篇 |
1994年 | 29篇 |
1993年 | 22篇 |
1992年 | 9篇 |
1991年 | 9篇 |
1990年 | 11篇 |
1989年 | 22篇 |
1988年 | 20篇 |
1987年 | 9篇 |
1986年 | 8篇 |
1985年 | 5篇 |
1984年 | 14篇 |
1983年 | 14篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1969年 | 1篇 |
排序方式: 共有698条查询结果,搜索用时 15 毫秒
101.
Alberto García-Salido Jordi Antón José David Martínez-Pajares Gemma Giralt Garcia Borja Gómez >Cortés Alfredo Tagarro Sylvia Belda Hofheinz Inmaculada Calvo Penadés Juan Carlos de Carlos Vicente Carlos Daniel Grasa Lozano Susanna Hernández Bou Rosa M. Pino Ramírez Esmeralda Núñez Cuadros Javier Pérez-Lescure Picarzo Jesús Saavedra Lozano Diana Salas-Mera Enrique Villalobos Pinto 《Anales de pediatría (Barcelona, Spain : 2003)》2021,94(2):116.e1-116.e11
A new paediatric multisystem inflammatory syndrome, linked to SARS-CoV-2, has been described. The clinical picture is variable and is associated with an active or recent infection due to SARS-CoV-2. A review of the existing literature by a multidisciplinary group of paediatric specialists is presented in this document. Later, they make recommendations on the stabilisation, diagnosis, and treatment of this syndrome. 相似文献
102.
103.
104.
Murakami T; Baron RL; Peterson MS; Oliver JH rd; Davis PL; Confer SR; Federle MP 《Radiology》1996,200(1):69
105.
J-B Liu† M Li‡§ H Chen† S-Q Zhong† S Yang¶ W-D Du¶ J-H Hao†† T-S Zhang‡‡ X-J Zhang¶ MP Zeegers§§¶¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(2):205-213
BACKGROUND: Linkage and association studies suggest that the human leucocyte antigen (HLA) region may be involved in the genetic susceptibility of vitiligo. HLA-A2 has been reported to be associated with vitiligo in some, but not all, studies. OBJECTIVE: To identify sources of the heterogeneity among studies and to quantify effect estimates, we examined the association of HLA-A2 with vitiligo in a meta-analysis of all observational studies comparing the frequencies of HLA-A2 between vitiligo individuals and controls during 1966-2005. METHODS: The summary odds ratio (OR) was calculated by using a fixed- or a random-effects model. Meta-regression analysis was undertaken to investigate the effects of study characteristics on the pooled OR. RESULTS: Eleven case-controlled studies fulfilled our inclusion criteria. The studies identified a total of 777 patients and 4820 controls. Meta-analysis showed a significantly increased frequency of HLA-A2 in vitiligo among cases [OR = 2.07, 95% confidence interval (CI) 1.67-2.58]. Heterogeneity was explained by the quality of the study and the ethnic background of the participants. Meta-regression analysis further showed that the percentage of familial vitiligo among the subjects had a significant effect on the pooled OR (P = 0.008). No study had a significant effect on the pooled OR and no publication bias presented in the studies analysed (P = 0.688). CONCLUSION: These findings strongly suggest an association between HLA-A2 and vitiligo. 相似文献
106.
X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features 总被引:3,自引:0,他引:3
The radiologic studies of 38 essentially untreated adults with X-linked hypophosphatemia (XLH) were reviewed to determine the prevalence of radiologic features, to compare the findings in men and in women, and to elucidate the natural history of the disease by comparing the findings in young, intermediate-age, and older patients. Bone-reinforcement lines were common, but no characteristic mineral mass alteration was established. Looser zones were more prevalent in older subjects. Osteoarthritis was common, occurring in the ankles, knees, feet, sacroiliac joints, and wrists. Enthesopathy was infrequent in the younger group but was present in every member of the intermediate and older groups and was often accompanied by extra ossicles. Curvatures of the lower-extremity long bones were common in all age groups. Three new skeletal alterations in XLH were found to be common: flaring of the iliac wings, trapezoidal distal femoral condyles, and alterations in talar morphology, including shortening of the talar neck and flattening of the talar dome. Technetium-99m methylene diphosphonate scintigrams of 17 subjects were often abnormal, depicting bowing deformity and focal tracer accumulation in diaphyseal cortices and in periarticular and extraarticular regions. The mean metabolic index was moderately elevated (4.0). Both radiographic and scintigraphic findings were more severe in men, consistent with hemizygosity. The natural history of untreated XLH in both sexes is characterized by the development of a variety of age-related skeletal abnormalities during adulthood. 相似文献
107.
Cristina Cabot Maria del Mar Grasa Jordi Estruch José-Antonio Fernández-López Xavier Remesar Marià Alemany 《Brain research bulletin》1998,46(6):529-534
Adult female Zucker lean and obese rats were treated for 14 days with 3.5 nm/kg oleoyl-estrone (OE) in liposomes (Merlin-2) through continuous i.v. injection with osmotic minipumps. Rat wt. and food intake were measured daily. On days 0, 3, 6, 10, and 14, groups of rats were killed and their hypothalamic nuclei [lateral preoptic (LPO), median preoptic (MPO), paraventricular (PVN), ventromedial (VMH), and arcuate (ARC)] were dissected, homogenized, and used for the measurement of corticosterone-releasing hormone (CRH) by radioimmunoassay. The OE treatment decreased food intake by 67.4% in lean and 62.6% in obese rats (means for 14 days). Body wt. decreased steadily in lean and obese rats, the gap between controls and treated rats becoming 11.5% of initial body wt. in the lean and 12.4% in the obese. The levels of CRH in the ARC nucleus were at least 10-fold higher than in the other nuclei. No changes in CRH were observed in any of the nuclei of obese rats, with levels up to day 6 similar to those of lean rats. In the lean rats, the LPO and ARC nuclei showed peaks on day 10, while the MPO showed no changes and the PVN and VMH nuclei showed a progressive increase, to a maximum at the end of the study (day 14). This contrasted with the peak of plasma adrenocorticotropic hormone (ACTH) and corticosterone (day 6 in lean and day 14 in obese rats). There was a definite lack of correlation between the plasma levels of these two hormones and the levels of CRH in the hypothalamic nuclei, and between the latter and the decreases in appetite in the rats. The loss of appetite induced by OE is not necessarily mediated by CRH, because the obese rats show an intense decrease in voluntary food intake but their hypothalamic nuclei CRH levels do not change at all. Hypothalamic nuclei CRH does not, necessarily, mediate the rise in glucocorticoids induced by OE treatment, because this is observed in lean and obese rats, lean rats increases being mismatched with those of hypothalamic CRH. The OE induced changes in hypothalamic CRH require a fully functional leptinergic pathway, because it is not observed in Zucker fa/fa rats lacking a working leptin receptor. This–indirectly–shows that leptin is needed for its synthesis or modulation. 相似文献
108.
109.
110.
Women worried about their familial breast cancer risk--a study on genetic advice in general practice
de Bock GH; Perk DC; Oosterwijk JC; Hageman GC; Kievit J; Springer MP 《Family practice》1997,14(1):40-43
AIMS: To ascertain whether women who consulted their GP because they
perceived themselves as at increased risk of familial breast cancer were
indeed at increased risk, and to evaluate potential strategies for
assessing genetic risk of breast cancer in general practice. METHODS:
Sixty-seven out of 81 women who had consulted their GP for advice about
their possible increased risk of developing breast cancer due to breast
cancer in the family were interviewed. Familial breast cancer risk was
assessed by a clinical geneticist. This assessment was compared with two
recent guidelines for referral for genetic counselling. RESULTS: More than
half (52%; n = 35) the women had a relative risk of two and over for
developing breast cancer, while another half of these 35 (25%; n = 17) had
a relative risk of three and over. All the women (n = 17) with a relative
risk of three and over were identified by means of the two current
guidelines for referral for genetic counselling, while more than half of
the women (61%; n = 11) with a relative risk between two and three were
identified. CONCLUSIONS: More than half the women concerned about their
familial risk of breast cancer are indeed at increased risk of breast
cancer. Current guidelines correctly identify women at high risk. However,
doubts about the health gain and feasibility of referral warrant caution,
and need further investigation.
相似文献